Skip to main content
Log in

ART at any CD4 cell count cost effective in sub-Sahara

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Ethiopia, Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda, Zambia and Zimbabwe

  2. US dollars

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ART at any CD4 cell count cost effective in sub-Sahara. PharmacoEcon Outcomes News 757, 5 (2016). https://doi.org/10.1007/s40274-016-3194-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3194-y

Navigation